Skip to main content
. 2022 Jul;23(7):2421–2430. doi: 10.31557/APJCP.2022.23.7.2421

Table 2.

Acute Rat Toxicity results of Tamoxifen*

Rat IP LD50 Classification Rat IV LD50 Classification Rat Oral LD50 Classification Rat SC LD50 Classification
Class 4 in AD Class 3 in AD Class 5 in AD  Class 5 in AD

† IP, intraperitoneal route of administration; IV, intravenous route of administration; Oral, oral route of administration; SC, subcutaneous route of administration; in AD, compound falls in applicability domain of models; *Tabulated results are based on Organisation for Economic Co-operation and Development (OECD) project from Way2Drug.